Health Imaging January 10, 2025
Hannah Murphy

Dozens of new artificial intelligence-enabled products have made their way onto the United States Food and Drug Administration’s list of approvals.

That brings the total number of cleared AI clinical applications to just over 1,000. Radiology leads the way in approvals by a mile, accounting for more than 70% of all clearances.

The latest update brings the total number of radiology-related FDA-approved applications to 758, with 35 new products being added to the list since August. Cardiology is next in line with 101 approvals, plus an additional 60 that also fall under the umbrella of radiology. Neurology sits at a distant third, with 35 listed approvals.

Notable companies in the most recent roundup include United Imaging, Avicenna.AI,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Provider, Radiology, Technology
Related Articles:
What A Potential FDA Red Dye No. 3 Ban Could Mean For Public Health
STAT+: Former Trump FDA, CMS heads lay out how his return could reshape health policy
The Overdue Imperative Of Cross-Racial Pulse Oximeters
FDA’s evolving regulatory framework for AI use in drug & device clinical trials and research
FDA warns of “important” clinical trial protocol deviations

Share This Article